VeriMomdihydromyricetin est-il sûr pendant la grossesse ?
No harmonised CLP reproductive classification (ECHA Annex VI) and no SCCS/CIR safety assessment raising reproductive concerns were identified. PubMed literature on dihydromyricetin (ampelopsin) focuses on antioxidant, hepatoprotective and metabolic effects; I found no convincing animal or human reproductive toxicity or teratogenicity data. Topical cosmetic absorption is expected to be low but measurable for a small polar flavonoid, so exposure is scored as low (evidence sources: PubMed, PubChem, CosIng, ECHA Annex VI absence).
Pregnancy-safe products containing dihydromyricetin
Related ingredients
Frequently asked questions
- dihydromyricetin est-il sûr pendant la grossesse ?
- No harmonised CLP reproductive classification (ECHA Annex VI) and no SCCS/CIR safety assessment raising reproductive concerns were identified. PubMed literature on dihydromyricetin (ampelopsin) focuses on antioxidant, hepatoprotective and metabolic effects; I found no convincing animal or human reproductive toxicity or teratogenicity data. Topical cosmetic absorption is expected to be low but measurable for a small polar flavonoid, so exposure is scored as low (evidence sources: PubMed, PubChem, CosIng, ECHA Annex VI absence).
- dihydromyricetin est-il sûr pendant l'allaitement ?
- No data indicating reproductive or lactation-specific toxicity or harmonised classifications. No demonstrated mechanism for transfer into milk; systemic exposure from topical use is likely low but measurable, so breastfeeding exposure is scored low (PubMed, PubChem, CosIng; no CIR/SCCS flags).
- dihydromyricetin est-il sûr pour la peau de bébé ?
- No infant-specific toxicity or developmental skin studies were identified. Hazard and mechanistic scores remain 0 due to absence of reproductive/endocrine evidence. Because infant skin has higher permeability and surface-area-to-weight, exposure is increased by +1 versus adult (adult e=1 → infant e=2) for measurable-absorption ingredients (sources: PubMed, CosIng, EWG; no harmonised CLP or SCCS/CIR restrictions).
- Comment VeriMom évalue-t-il dihydromyricetin ?
- VeriMom évalue dihydromyricetin à 93/100 (pas de risques connus) sur la base du statut EU CosIng, des classifications ECHA et des études PubMed.
- Quelles sont les alternatives sûres à dihydromyricetin pendant la grossesse ?
- Consultez notre liste d'alternatives sûres à dihydromyricetin basée sur une fonction similaire et une classification sans risques connus.
Vérifiez chaque étiquette en 2 secondes
Obtenez VeriMom gratuitement — scannez n'importe quel produit et voyez le score de sécurité grossesse instantanément.
Avis Médical
Ces informations sont fournies à titre éducatif uniquement et ne constituent pas un avis médical. Les scores de sécurité sont basés sur des données accessibles au public et peuvent ne pas refléter tous les risques. Consultez toujours votre professionnel de santé avant d'utiliser tout produit pendant la grossesse ou l'allaitement.